Results 101 to 110 of about 36,868 (221)
British Journal of Clinical Pharmacology, Volume 92, Issue 9, Page 3246-3256, September 2026.Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind +7 more
wiley +1 more source
Early and late Biliary Complications of Laparoscopic Cholecystectomy in Acute Cholecystitis
مجله كليه طب الكندي, 2011 Background: Laparoscopic cholecystectomy has become the standard of care for the elective management of cholelithiasis. Little information exists, however, regarding the appropriateness of this procedure in the setting of acute symptomatology. Objective:
Omar Salem Khattab,
doaj
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT A 63‐year‐old man presented with melena and severe anemia 18 years after nephrectomy for clear cell renal cell carcinoma. Imaging and biopsy confirmed duodenal and pancreatic metastases mimicking pancreaticobiliary malignancy. He underwent pancreaticoduodenectomy.
Ankit Kulkarni +6 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT An 85‐year‐old man developed acute neurologic dysfunction, severe thrombocytopenia, microangiopathic hemolytic anemia, and ADAMTS13 activity of 4.6% after TMP‐SMX reexposure. Seven plasma‐exchange sessions plus corticosteroids produced rapid recovery.
Renee Morecroft +6 more
wiley +1 more source
RISK OF CONVERSION OF OPERATIONAL INTERVENTION IN ACUTE CHOLECYSTITIS, COMPLICATED BY PERITONITIS
Arta Medica, 2019 Calculous acute cholecystitis, in emergency abdominal surgery, is ranked second after acute appendicitis. A scientific study was undertaken regarding the effectiveness and the priorities of the active involvement tactics in the treatment of these ...
Boris Zaporozhchenko +4 more
doaj
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.In this multicentre real‐world post‐marketing surveillance (rPMS) study conducted in Taiwan, reductions in body weight and no new safety issues were observed among adults with obesity treated with liraglutide. ABSTRACT Introduction This prospective study (NCT06283641) was the first real‐world, multicentre, post‐marketing surveillance of GLP‐1 receptor ...
Shih‐Te Tu +15 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9701-9703, October 2026.
Mika Ukkonen +5 more
wiley +1 more source
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.The comparative pharmacology and cardiometabolic outcomes of semaglutide, liraglutide and tirzepatide, integrating evidence from major clinical trial programs and meta‐analyses. ABSTRACT Background Cardiometabolic disorders such as type 2 diabetes mellitus (T2DM), obesity and cardiovascular disease (CVD) remain major global health challenges.
Hiba Bawadi +4 more
wiley +1 more source